Management of Obstructive Colon Tumors in Istanbul

Last updated: June 17, 2022
Sponsor: Istanbul Medipol University Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colon Cancer

Treatment

N/A

Clinical Study ID

NCT05424939
E-10840098-772.02-1214
  • Ages > 18
  • All Genders

Study Summary

The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Acute intestinal obstruction due to colon cancer either preoperatively orintraoperatively detected
  • Clinical findings of obstruction (Abdominal distention and pain, nausea or vomiting,and absence of bowel movements) confirmed by abdominal x-ray or CT

Exclusion

Exclusion Criteria:

  • Benign diseases
  • Emergency surgery due to bleeding, perforation and other non-obstructive situations
  • Recurrent colon tumors
  • Rectal cancer

Study Design

Total Participants: 500
Study Start date:
June 01, 2022
Estimated Completion Date:
May 31, 2024

Connect with a study center

  • Medipol Mega Hospital

    Istanbul, 34214
    Turkey

    Active - Recruiting

  • Medipol University Bahcelievler Hospital

    Istanbul, 34196
    Turkey

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.